Integra Lifesciences Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Public

  • Employees
  • 4,396

Employees

  • Stock Symbol
  • IART

Stock Symbol

  • Investments
  • 51

  • Share Price
  • $11.91
  • (As of Wednesday Closing)

Integra Lifesciences General Information

Description

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1100 Campus Road
  • Princeton, NJ 08540
  • United States
+1 (609)
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Stock Exchange
NAS
Corporate Office
  • 1100 Campus Road
  • Princeton, NJ 08540
  • United States
+1 (609)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Integra Lifesciences Stock Performance

As of 18-Jun-2025, Integra Lifesciences’s stock price is $11.91. Its current market cap is $926M with 77.7M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.91 $12.15 $11.60 - $32.66 $926M 77.7M 1.15M -$0.38

Integra Lifesciences Financials Summary

As of 31-Mar-2025, Integra Lifesciences has a trailing 12-month revenue of $1.62B.

In Thousands,
USD
TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 3,409,040 3,461,915 4,818,305 5,885,339
Revenue 1,624,308 1,610,527 1,541,573 1,557,666
EBITDA 160,876 179,955 238,944 369,971
Net Income (28,955) (6,944) 67,741 180,550
Total Assets 4,052,751 4,037,424 3,781,988 3,889,758
Total Debt 2,018,937 1,984,563 1,681,682 1,615,359
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Integra Lifesciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Integra Lifesciences‘s full profile, request access.

Request a free trial

Integra Lifesciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for re
Surgical Devices
Princeton, NJ
4,396 As of 2024

Lewisville, TX
 

Marietta, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Integra Lifesciences Competitors (28)

One of Integra Lifesciences’s 28 competitors is Orthofix International, a Formerly PE-Backed company based in Lewisville, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orthofix International Formerly PE-Backed Lewisville, TX
Mimedx Group Corporation Marietta, GA
Zimmer Biomet Holdings Corporation Warsaw, IN
SeaSpine Holdings Corporate Backed or Acquired Carlsbad, CA
Apyx Medical Corporation Clearwater, FL
You’re viewing 5 of 28 competitors. Get the full list »

Integra Lifesciences Patents

Integra Lifesciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250032627-A1 Therapeutic sealants based upon drug conjugates Pending 14-Jul-2023
US-D1040168-S1 Display screen with an animated graphical user interface Active 06-Jul-2022
US-D1053889-S1 Display screen with a graphical user interface Active 06-Jul-2022
US-12059509-B1 Method and matrix for tissue regeneration Active 05-May-2020
US-20210308330-A1 Devices and methods for nerve regeneration Active 06-Apr-2020 A61L27/3675
To view Integra Lifesciences’s complete patent history, request access »

Integra Lifesciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Integra Lifesciences Investments & Acquisitions (51)

Integra Lifesciences’s most recent deal was a Corporate Asset Purchase with Integra Lifesciences (Manufacturing Facility in Plainsboro, New Jersey) for . The deal was made on 01-Oct-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Integra Lifesciences (Manufacturing Facility in Plainsboro, New Jersey) 01-Oct-2024 Corporate Asset Purchase Buildings and Property
Acclarent 01-Apr-2024 Merger/Acquisition Surgical Devices
Surgical Innovation Associates 06-Dec-2022 Merger/Acquisition Surgical Devices
ACell 20-Jan-2021 Merger/Acquisition Surgical Devices
Rebound Therapeutics 09-Sep-2019 Merger/Acquisition Surgical Devices
You’re viewing 5 of 51 investments and acquisitions. Get the full list »

Integra Lifesciences ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

22.81 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,673

Rank

Percentile

Healthcare

Industry

of 564

Rank

Percentile

Medical Devices

Subindustry

of 196

Rank

Percentile

To view Integra Lifesciences’s complete esg history, request access »

Integra Lifesciences Exits (6)

Integra Lifesciences’s most recent exit was on 24-Feb-2017 from Derma Sciences. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Derma Sciences 24-Feb-2017 Completed
Avraham Pharma 25-Feb-2016 Completed
  • 6 buyers
Avraham Pharma 17-Sep-2014 Completed
  • 5 buyers
SeaSpine Holdings 23-May-2011 Completed
Welch Allyn 01-May-2010 Merger/Acquisition Completed
You’re viewing 5 of 6 exits. Get the full list »

Integra Lifesciences Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Surgical Innovation Associates Chicago, IL 2016
Integra Spine Akron, OH 1998
Miltex Dental York, PA
NMT Medical (Three Product Lines) Plainsboro Center, NJ

Integra Lifesciences FAQs

  • When was Integra Lifesciences founded?

    Integra Lifesciences was founded in 1989.

  • Where is Integra Lifesciences headquartered?

    Integra Lifesciences is headquartered in Princeton, NJ.

  • What is the size of Integra Lifesciences?

    Integra Lifesciences has 4,396 total employees.

  • What industry is Integra Lifesciences in?

    Integra Lifesciences’s primary industry is Surgical Devices.

  • Is Integra Lifesciences a private or public company?

    Integra Lifesciences is a Public company.

  • What is Integra Lifesciences’s stock symbol?

    The ticker symbol for Integra Lifesciences is IART.

  • What is the current stock price of Integra Lifesciences?

    As of 18-Jun-2025 the stock price of Integra Lifesciences is $11.91.

  • What is the current market cap of Integra Lifesciences?

    The current market capitalization of Integra Lifesciences is $926M.

  • What is Integra Lifesciences’s current revenue?

    The trailing twelve month revenue for Integra Lifesciences is $1.62B.

  • Who are Integra Lifesciences’s competitors?

    Orthofix International, Mimedx Group, Zimmer Biomet Holdings, SeaSpine Holdings, and Apyx Medical are some of the 28 competitors of Integra Lifesciences.

  • What is Integra Lifesciences’s annual earnings per share (EPS)?

    Integra Lifesciences’s EPS for 12 months was -$0.38.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »